Literature DB >> 19841104

Oestradiol assays: fitness for purpose?

Jonathan G Middle1, John W Kane.   

Abstract

In this review we discuss the analytical inadequacies of oestradiol assays in relation to the clinical requirements for performing them, and make recommendations for their improvement. The measurement of oestradiol can be requested in a number of clinical scenarios (precocious puberty, infertility, assisted conception, hormone replacement therapy). The very wide dynamic range of oestradiol concentrations is a huge challenge for routine assays, which they are unlikely to meet on theoretical as well as practical grounds. The EQA performance of oestradiol assays in terms of trueness, comparability, recovery and analytical sensitivity leaves much to be desired and indicates that calibration is compromised by poor analytical specificity. To make oestradiol assays fit for purpose requires concerted action by all stakeholders to define analytical quality specifications for the various clinical scenarios involved, and then to encourage concerted action by the diagnostic industry to use the steroid reference measurement system to improve specificity, trueness and traceability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841104     DOI: 10.1258/acb.2009.009102

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  4 in total

Review 1.  Challenges to the measurement of oestradiol: comments on an endocrine society position statement.

Authors:  Julie D Newman; David J Handelsman
Journal:  Clin Biochem Rev       Date:  2014-05

2.  Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty

Authors:  Stefanie Schubert; Amalie H. Hvelplund; Aase Handberg; Søren Hagstroem; Tina Lund Leunbach
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-12-30

3.  Oestradiol measurement during fulvestrant treatment for breast cancer.

Authors:  Laura J Owen; Phillip J Monaghan; Anne Armstrong; Brian G Keevil; Claire Higham; Zena Salih; Sacha Howell
Journal:  Br J Cancer       Date:  2019-01-25       Impact factor: 7.640

Review 4.  Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones.

Authors:  Timothy J Key; Paul N Appleby; Naomi E Allen; Gillian K Reeves
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-16       Impact factor: 4.254

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.